Intravitreal Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: The Second Year of a Prospective Study
To access this article, please choose from the options below
See accompanying Editorial on page 1.
PII: S0002-9394(09)00103-2
doi:10.1016/j.ajo.2009.02.006
© 2009 Elsevier Inc. All rights reserved.
Refers to article:
- The As-Needed Treatment Strategy for Choroidal Neovascularization: A Feedback-Based Treatment System
